Detalles de la búsqueda
1.
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in Mice.
J Pharmacol Exp Ther
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637015
2.
Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.
J Pharmacol Exp Ther
; 382(1): 44-53, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489781
3.
Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.
Bioorg Chem
; 120: 105641, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093692
4.
Climbing behavior by mice as an endpoint for preclinical assessment of drug effects in the absence and presence of pain.
Front Pain Res (Lausanne)
; 4: 1150236, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139343
5.
Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice.
Front Pain Res (Lausanne)
; 4: 1281698, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37886350
6.
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.
Pharmacol Res Perspect
; 11(4): e01111, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381112
Resultados
1 -
6
de 6
1
Próxima >
>>